160 related articles for article (PubMed ID: 22735222)
1. Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis.
Rotta I; Otuki MF; Sanches AC; Correr CJ
Rev Assoc Med Bras (1992); 2012; 58(3):308-18. PubMed ID: 22735222
[TBL] [Abstract][Full Text] [Related]
2. Topical antifungal treatments for tinea cruris and tinea corporis.
El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review.
Rotta I; Sanchez A; Gonçalves PR; Otuki MF; Correr CJ
Br J Dermatol; 2012 May; 166(5):927-33. PubMed ID: 22233283
[TBL] [Abstract][Full Text] [Related]
4. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
5. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
Korting HC; Kiencke P; Nelles S; Rychlik R
Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of interdigital tinea pedis].
Korting HC; Rychlik R; Pfeil B
Dtsch Med Wochenschr; 2003 Sep; 128(36):1819-24. PubMed ID: 12964099
[TBL] [Abstract][Full Text] [Related]
7. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
8. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
Rosen T
J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review.
van Zuuren EJ; Fedorowicz Z; El-Gohary M
Br J Dermatol; 2015 Mar; 172(3):616-41. PubMed ID: 25294700
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of topical treatments for fungal infections of the skin and nails of the feet.
Hart R; Bell-Syer SE; Crawford F; Torgerson DJ; Young P; Russell I
BMJ; 1999 Jul; 319(7202):79-82. PubMed ID: 10398626
[TBL] [Abstract][Full Text] [Related]
11. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
12. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.
Rotta I; Ziegelmann PK; Otuki MF; Riveros BS; Bernardo NL; Correr CJ
JAMA Dermatol; 2013 Mar; 149(3):341-9. PubMed ID: 23553036
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
Spiekermann PH; Young MD
Arch Dermatol; 1976 Mar; 112(3):350-2. PubMed ID: 769697
[TBL] [Abstract][Full Text] [Related]
17. Topical therapy for dermatophytoses: should corticosteroids be included?
Erbagci Z
Am J Clin Dermatol; 2004; 5(6):375-84. PubMed ID: 15663334
[TBL] [Abstract][Full Text] [Related]
18. A clinical and mycological assessment of tioconazole solution in the treatment of superficial dermatomycoses.
del Palacio Hernanz A; Lopez Gomez S; Iglesias Diez L
Clin Ther; 1987; 9(3):333-8. PubMed ID: 3300990
[TBL] [Abstract][Full Text] [Related]
19. [Oral Antifungal Drugs in the Treatment of Dermatomycosis].
Tsunemi Y
Med Mycol J; 2016; 57(2):J71-5. PubMed ID: 27251319
[TBL] [Abstract][Full Text] [Related]
20. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
Gupta AK; Einarson TR; Summerbell RC; Shear NH
Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
